The CFI-funded NanoMed Fab Center sets itself apart from any other facility within Canada by going beyond developing nanotechnology at a fundamental level. The NanoMedFab is interested in the full spectrum of nanotechnology research and development including nanoparticle fabrication, characterization, evaluation modules and a targeting ligand synthesis all with a distinct focus on biomedical applications. The NanoMedFab Center contains a nanoparticle-focused Good Manufacture Production (GMP) facility unique in Canada. Located on the first floor of the Max Bell Research Building at the University Health Network in collaboration with the University of Toronto, this 2200 ft2 facility is a crucial component for translational research. It will fill the gap between fabricating nanoparticles for preclinical research and agents suitable for first-in-human trials.